Business Context and Reporting Period
This Form 6-K filing by DHT Holdings, Inc. (NYSE: DHT) covers the month of April 2012. The report addresses a regulatory notice received from the New York Stock Exchange (NYSE) regarding the Company's compliance with continued listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the average closing price of the Company's common stock, which fell below $1.00 per share over a consecutive 30 trading-day period.
Material Changes
The primary material change reported is the Company's non-compliance with NYSE listing standards due to the decline in its stock price. This status change was triggered by the average closing price remaining under the $1.00 threshold for 30 consecutive days.
Outlook, Risks, and Management Commentary
Management has acknowledged the receipt of the NYSE notice on April 24, 2012. Under NYSE rules, the Company has been granted a six-month cure period to restore compliance by bringing its share price and average share price above $1.00. The filing incorporates a press release dated April 25, 2012, detailing this event. No other risks, contingencies, or unusual items are described in the text.
Investor Verification Checklist
- Verify the current trading price of DHT Holdings, Inc. common stock relative to the $1.00 threshold.
- Confirm the specific end date of the six-month cure period granted by the NYSE.
- Review the attached press release (Exhibit 99.1) for any additional management commentary on the stock price decline.
- Monitor subsequent filings for updates on the Company's progress in meeting the listing standards.